Pharmaceutical

Company News

DelMar Pharmaceuticals (OTCQX:DMPID) announced that the Company will ring the Nasdaq Opening Bell on Thursday, July 14 in honor of its recent listing on Nasdaq. Members of the DelMar Pharmaceuticals corporate team including Jeffrey Bacha, Chairman and CEO, will ring the opening bell in celebration of the listing.

DelMar Pharmaceuticals (OTCQX:DMPIDannounced that the Company will ring the Nasdaq Opening Bell on Thursday, July 14 in honor of its recent listing on Nasdaq. Members of the DelMar Pharmaceuticals corporate team including Jeffrey Bacha, Chairman and CEO, will ring the opening bell in celebration of the listing.
DelMar Pharmaceuticals Chariman and CEO, Jeffrey Bacha, stated:

This uplisting to Nasdaq is a milestone achievement for the Company, and one that we believe presents the opportunity for exposure to a broader and more diverse investor audience. We would like to take this moment to thank and acknowledge the employees, investors, and partners who have supported the Company and helped facilitate this day. Due to strong scientific leadership coupled with this increased visibility on a senior exchange, we believe we are well-positioned for future growth and recognition among security holders.

Connect with DelMar Pharmaceuticals (OTCQX:DMPID) to receive an Investor Presentation.
 

MARKETS

Markets
TSX18648.92+341.01
TSXV587.57+13.66
DOW29683.74+548.75
S&P 5003719.04+71.75
NASD11051.64+222.13
ASX6462.00-34.20

COMMODITIES

Commodities
Gold1656.72+0.23
Silver18.84-0.01
Copper3.37+0.01
Palladium2142.50+13.50
Platinum863.50+3.50
Oil82.28+0.13
Heating Oil3.34+0.01
Natural Gas7.04+0.09

DOWNLOAD FREE REPORTS

×